Largest, Longest Real-World Study of Migraine in U.S. Veterans Finds that Nerivio® Helps Patients Successfully Skip Prescribed Migraine Medications in 3-out-of-4 of Their Migraine Attacks

Data ReadoutpositiveNerivioPositive

AI Analysis

Summary

Theranica announced results from a large real-world study of Nerivio in nearly 30,000 migraine treatments among U.S. veterans, showing the wearable device helped patients skip prescribed medications in 75% of attacks. The peer-reviewed data supports Nerivio's role as a non-pharmacological alternative for migraine management.

Clinical Trial Data

Primary Endpoint

Met

Outcome Details

Real-world study of nearly 30,000 treatments in U.S. veterans found Nerivio helped patients skip prescribed migraine medications in 3-out-of-4 migraine attacks

Importance:6/10

Sentiment:

0.75

real-world evidencemigraineveteranswearable devicedrug-free treatment

Related Companies

$WHSI $WHEN

Read the original article

Published by PR Newswire Pharma on August 6, 2026 1:06 PM

Read Original